X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
5Y CAGR+57.8%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

5Y CAGR
+57.8%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
9.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$29.36M+1568.0%
2024$1.76M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$3.00M+546.4%
2019$-672000.00-119.8%
2018$3.40M+1842.1%
2017$-195000.00+35.0%
2016$-300000.00-